Disease & Therapy FAQs | Stem Cell Treatment Options

Yes. Stem Cell Care India uses mesenchymal stem cells (MSCs) to support regeneration of damaged cartilage, reduce inflammation, and improve joint movement in osteoarthritis. The approach targets the underlying joint degeneration, not just the pain.

Stem cell therapy can help regulate immune activity, ease chronic inflammation, and support recovery of normal immune responses — which may benefit patients with rheumatoid arthritis and systemic lupus.

It can be, depending on the case. Regenerative approaches for ankylosing spondylitis and chronic back pain focus on reducing inflammation and supporting tissue repair around affected joints and discs, alongside physiotherapy.

Yes. Regenerative approaches for osteoporosis, osteopenia, and osteomalacia aim to support bone density and remodeling alongside standard bone-health management. These bone-loss conditions are evaluated individually before any protocol is proposed.

Yes. Regenerative treatment for fibromyalgia aims to ease widespread pain and inflammation, while sports-injury protocols focus on accelerating soft-tissue healing so patients can return to activity sooner.

Yes, depending on severity. Regenerative options exist for avascular necrosis, degenerative disc disease, sciatic nerve injury and sciatica, and shoulder injuries, aimed at reducing inflammation and supporting tissue repair around the affected joint or nerve.

Regenerative approaches for gout aim to calm joint inflammation between flares, while meniscus-tear protocols focus on supporting cartilage repair and reducing the need for more invasive knee surgery. Suitability depends on the extent of joint or cartilage damage.

Yes. Regenerative treatment for tennis elbow and other forms of tendonitis aims to reduce inflammation and stimulate tendon tissue repair, often as an alternative for patients who haven't responded to rest, physiotherapy, or standard injections.

Regenerative treatment for carpal tunnel syndrome aims to reduce inflammation around the compressed nerve and support tissue healing, often considered for patients looking to avoid or delay surgical release.

Emerging research shows promising results. Regenerative treatments are available for both Type 1 and Type 2 diabetes, aimed at supporting beta-cell function and improving insulin responsiveness.

No. Type 1 diabetes involves autoimmune destruction of insulin-producing cells, while Type 2 primarily involves insulin resistance — the regenerative approach and supportive plan differ and are confirmed during evaluation.

Yes, regenerative support is also used for related complications such as diabetic foot ulcers and diabetic neuropathy, aimed at supporting tissue healing and nerve health.

Regenerative support for prediabetes and metabolic syndrome is aimed at improving insulin sensitivity and reducing chronic inflammation, alongside standard lifestyle and dietary management, rather than replacing it.

Regenerative approaches during and after pregnancy are approached with particular caution. Most supportive stem cell care for gestational diabetes focuses on the postpartum period, aimed at improving longer-term insulin responsiveness alongside standard maternal care.

Regenerative support for hypothyroidism and related thyroid disorders aims to help support thyroid tissue health, alongside standard hormone-replacement management rather than replacing it.

Stem cell therapies are available that may support regeneration of cardiac tissue damaged by conditions such as heart failure or a prior heart attack.

Advanced regenerative options are explored for kidney disease with the goal of supporting tissue repair and functional restoration, as part of ongoing innovation in regenerative medicine.

Mesenchymal stem cells are used to help calm inflammatory processes and support tissue repair in COPD and other lung conditions, aiming to improve lung function and support recovery.

Regenerative treatments are offered for liver conditions such as cirrhosis, aimed at supporting liver regeneration, restoring function, and improving overall liver capacity over time.

Yes, regenerative approaches are also used for vascular conditions such as erectile dysfunction and critical limb ischemia, aimed at supporting blood vessel and tissue health.

Yes. Regenerative approaches for Buerger's disease aim to support blood vessel health and circulation in the limbs, alongside standard vascular care, to help manage this rare inflammatory condition.

Yes. Regenerative treatment for pulmonary fibrosis aims to slow scar-tissue buildup in the lungs, while therapy for pancreatitis focuses on calming inflammation and supporting pancreatic tissue repair. Both are evaluated individually given how variable severity can be.

Yes. Regenerative treatment for NAFLD aims to support liver tissue regeneration and reduce fat-related inflammation, alongside standard dietary and metabolic management of the condition.

Stem cell therapy for cardiomyopathy aims to support regeneration of weakened heart muscle tissue and improve cardiac function, as part of a broader cardiovascular care plan alongside standard cardiology treatment.

These interventions aim to slow neurological decline, support nerve health, and improve daily quality of life for patients with Parkinson's disease or Alzheimer's. They do not reverse or cure the underlying disease.

Yes. Stem cell therapy for spinal cord injury focuses on stimulating nerve repair and enhancing recovery, aiming to improve sensory and motor function.

Regenerative interventions such as MSC therapy have shown encouraging results in some studies for slowing MS progression and supporting neurological recovery, though outcomes vary by patient and disease stage.

Yes, regenerative support is offered for ALS/MND, aimed at supporting nerve cell health and slowing functional decline alongside standard neurological care. This is a progressive, currently incurable condition, so the focus is quality-of-life support, not a cure.

Regenerative therapy for stroke recovery focuses on supporting neurological repair alongside physiotherapy and rehabilitation, aiming to improve functional recovery beyond standard rehab alone.

Yes, regenerative therapy for cerebral palsy is offered alongside physiotherapy and occupational therapy, aimed at supporting motor function and development. Every pediatric case is evaluated individually first.

Regenerative support for ataxia and muscular dystrophy focuses on slowing functional decline and supporting muscle and nerve tissue health. Both are progressive genetic conditions, so therapy is supportive rather than curative.

Yes. Regenerative options for brain injury and spinal muscular atrophy aim to support nerve repair and functional recovery alongside physiotherapy and rehabilitation.

Regenerative therapy for intellectual disabilities and global developmental delay is offered alongside speech, occupational, and behavioral therapy, aimed at supporting neurological development. Every pediatric case is evaluated individually.

Yes, regenerative support is available for Huntington's disease, aimed at supporting nerve cell health and slowing functional decline. This is a progressive genetic condition, so the focus is quality-of-life support rather than a cure.

Regenerative support for epilepsy is aimed at improving nerve-cell stability alongside standard anti-seizure treatment, while therapy for peripheral neuropathy focuses on supporting nerve repair and reducing pain and numbness.

Regenerative support for myasthenia gravis and Guillain-Barré syndrome is aimed at helping regulate the immune activity that attacks nerve-muscle signaling, alongside standard neurological treatment for these autoimmune nerve conditions.

Regenerative approaches for trigeminal neuralgia aim to support nerve healing and reduce the chronic facial nerve pain associated with the condition, alongside standard neurological pain management.

Yes. Regenerative therapies are used to help manage the progression of eye conditions including optic nerve atrophy, retinitis pigmentosa, and optic nerve hypoplasia, as part of a broader supportive eye-care plan.

Yes. Regenerative therapies for glaucoma and age-related macular degeneration aim to support retinal and optic nerve tissue health, helping slow vision loss as part of a broader supportive eye-care plan.

Regenerative approaches exist for eye injuries, retinal detachment, and septo-optic dysplasia, aimed at supporting tissue repair and visual function. Suitability depends on the extent of damage.

Regenerative approaches for dry eye disease and corneal damage aim to support tear-film-producing tissue and corneal surface healing, typically alongside standard ophthalmic care.

Regenerative approaches for diabetic retinopathy aim to support retinal tissue health and slow vision-threatening changes, typically alongside standard diabetic eye care and blood-sugar management.

Regenerative treatment for uveitis aims to help calm inflammation inside the eye and support tissue healing, typically alongside standard ophthalmic anti-inflammatory care.

Anti-aging and wellness-focused regenerative treatments aim to support tissue health, general vitality, and long-term wellness — these are wellness applications, not medical cures.

Regenerative treatments for hair loss aim to support scalp tissue health and hair follicle activity as part of a broader hair-restoration approach; results vary by cause and patient.

Regenerative treatments are offered for infertility arising from either the male or female reproductive system, focused on supporting reproductive tissue health.

Yes. Regenerative treatments for vitiligo aim to support pigment-cell activity and skin repair, while therapy for skin burns focuses on accelerating tissue healing and reducing scarring.

Regenerative support is offered for Peyronie's disease, aimed at supporting tissue elasticity and reducing scar-tissue-related curvature, as part of a broader male reproductive-health plan.

Wellness-focused regenerative treatments for menopause and andropause aim to support hormonal tissue health and overall vitality. These are supportive wellness applications, not a replacement for standard hormonal care.

Regenerative treatments for PCOS and premature ovarian failure aim to support ovarian tissue health and hormonal balance as part of a broader female fertility and reproductive-health plan.

Regenerative support for low testosterone and hypogonadism aims to support hormone-producing tissue health as part of a broader male reproductive and wellness plan, alongside standard hormonal evaluation.

Regenerative therapy for Sjögren's syndrome and Hashimoto's disease aims to help regulate immune activity and ease chronic inflammation associated with these autoimmune conditions.

Yes. Regenerative approaches for Crohn's disease, ulcerative colitis, and inflammatory bowel disease aim to calm gut inflammation and support tissue repair in the digestive tract, alongside standard gastroenterology care.

Regenerative treatment for psoriasis and connective tissue disorders focuses on reducing inflammation and supporting skin and tissue repair. Results vary depending on disease severity and duration.

Regenerative support for Down syndrome and related genetic conditions is aimed at supporting general development and quality of life alongside standard therapies. This is a supportive approach, not a treatment for the underlying genetic cause.

Regenerative approaches for celiac disease and scleroderma aim to help regulate immune activity and support tissue repair, alongside standard dietary or rheumatological management of these autoimmune conditions.

Regenerative treatment for psoriatic arthritis and vasculitis aims to help regulate immune activity and reduce the chronic inflammation affecting joints or blood vessels in these autoimmune conditions.

Regenerative approaches for IBS aim to help calm gut inflammation and support digestive-tract tissue health, alongside standard dietary and gastroenterology management of symptoms.

Depending on the condition, treatment may be delivered as a local injection directly into the affected tissue, given intravenously, or implanted at the specific site of concern — see our treatment procedure overview.

Most procedures are minimally invasive, with only mild, short-lived discomfort for some patients. Recovery is typically fast, allowing most patients to resume regular activities without an extended rest period.

Most patients resume normal activities within a couple of days, though exact recovery time depends on the condition treated and how treatment was administered — see post-treatment care.

Most patients report improvements a few weeks to a few months after therapy. For chronic conditions like osteoarthritis, improved mobility and reduced pain are typically gradual effects that build over time.

Yes. For degenerative conditions, additional sessions over time can help maintain or enhance the therapy's effectiveness — see our treatment protocol for how repeat sessions are planned.

Autologous stem cells are collected from the patient's own body, while allogeneic cells come from a donor source. The choice depends on the condition being treated, the patient's health, and the specific protocol recommended after a medical evaluation.

Yes. Stem cell therapy is sometimes combined with PRP to add growth factors that may support tissue healing, particularly for orthopedic and soft-tissue conditions. Whether combination therapy is appropriate is decided case by case.

Success rates vary widely by condition, severity, and patient factors, and are not guaranteed for any individual case. Patients can review documented outcomes in our patient testimonials and discuss condition-specific expectations during a free medical evaluation.

Regenerative stem cell therapy is used across 98+ conditions grouped into orthopedic & joint, metabolic, cardiovascular & organ-specific, neurological & spinal, eye, aging & fertility, and autoimmune, digestive & genetic categories. Browse the full breakdown in our Centre of Excellence directory, or jump to any category using the on-this-page menu above.

Eligibility is determined by a combination of factors including the specific medical condition, age, general health, and the goals of therapy, confirmed through a free medical evaluation.

Yes. Advanced age does not automatically rule out treatment — patients of all ages, including older adults, can often see positive results, particularly for degenerative conditions.

Most conditions are addressed in a single treatment visit, though chronic or degenerative conditions may benefit from periodic follow-up sessions — see our treatment protocol for how session frequency is planned. The exact number is confirmed individually based on condition, severity, and response to initial therapy.

Yes, India issues medical visas for patients traveling for treatment, and the clinical team can help guide international patients through the required documentation once a treatment plan has been confirmed — see our contact page to get started.

A history of cancer requires careful individual evaluation, since regenerative treatment may not be appropriate for all cancer survivors or active cancer patients. This is assessed case by case during the medical evaluation before any protocol is proposed.

Stem cell therapy using adult, non-embryonic cells is practiced in India under the National Ethical Guidelines for Biomedical and Health Research issued by ICMR, and most applications remain investigational rather than fully approved treatments — see our full treatment disclaimer for details.

Generally not. Most insurance plans do not cover stem cell treatments considered experimental or investigational, so patients typically self-fund the cost — see our pricing guide.

Look for:

• Experienced and certified medical staff
• Clear patient protocols
• Documented safety and past patient outcomes — see our patient testimonials
• Transparent, structured follow-up and monitoring

Patients can contact the clinical team to learn about ongoing clinical trials, eligibility, and requirements to support informed decision-making.

Potential risks can include infection, immune system reactions, lack of improvement, and, very rarely, abnormal behavior of the treated cells. This is why therapy should always be administered under qualified supervision — see safety and risks.

Stem Cell Care India uses adult stem cells, including MSCs and other non-embryonic sources, limiting the ethical concerns associated with embryonic cell use while aiming to provide safe, effective options — see our informed consent information.

Some clinics operate with limited regulation and offer treatments not backed by adequate evidence. Confirm that a facility follows strict medical supervision, established protocols, and ethical guidelines — see our quality commitment.

The field is moving toward regenerative medicine for organ repair, genetic correction, more personalized patient-specific therapies, and greater use of exosomes and next-generation cell therapies for improved outcomes.

Patients most often ask about osteoarthritis, diabetes, neurological conditions, autoimmune disease, and organ-specific conditions such as kidney or liver disease. MSCs are most commonly used for their anti-inflammatory and immunomodulatory properties, though suitability depends on the individual case — browse the full Centre of Excellence directory.